Research output per year
Research output per year
Fingerprint
Dive into the research topics where Wietse Geens is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prognostic Value of O-(2-18F-Fluoroethyl)-l-Tyrosine PET for Patients with Recurrent Glioblastoma.
Geens, W., Buyck, F., Raes, L., Schwarze, J. K., Awada, G., De Sutter, S., Bruneau, M., Vandemeulebroucke, J., Everaert, H., Neyns, B. & Duerinck, J., 1 Jun 2026, In: Journal of Nuclear Medicine. 67, 6, p. 857-863 7 p.Research output: Contribution to journal › Article › peer-review
-
Segmentation of Glioblastoma Infiltration Using Hybrid Labels from MRI and [18F]FET PET
De Sutter, S., Dirks, I., Raes, L., Geens, W., Everaert, H., Bourgeois, S., Duerinck, J. & Vandemeulebroucke, J., 2026, Machine Learning in Medical Imaging - 16th International Workshop, MLMI 2025, Held in Conjunction with MICCAI 2025, Proceedings. Cui, Z., Rekik, I., Suk, H.-I., Ouyang, X., Sun, K. & Wang, S. (eds.). Springer Science and Business Media Deutschland GmbH, p. 411-420 10 p. (Lecture Notes in Computer Science; vol. 16241 LNCS).Research output: Chapter in Book/Report/Conference proceeding › Conference paper
-
Elucidating the spatial heterogeneity of glioblastoma by integrating multimodal imaging with single-nucleus RNA sequencing
Srinivasan, A. N., Vara Pérez, M., De Sutter, S., Leduc, S., Geens, W., Geeraerts, X., Kancheva, D., Roelandt, R., Bruneau, M., Tuyaerts, S., Stevens, L., Neyns, B., Vandemeulebroucke, J., Duerinck, J. & Movahedi, K., 2025, (Unpublished). 1 p.Research output: Unpublished contribution to conference › Poster
-
Extent of resection and its association with overall survival in newly diagnosed IDH wildtype glioblastoma treated with concomitant radiochemotherapy: a systematic review and meta-analysis
Geens, W., Rizani, G., Del Gaudio, N., Buyck, F., Van Gestel, F., Bruneau, M., Neyns, B. & Duerinck, J., 2025, In: Brain and spine . 5, 9 p., 105867.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)3 Downloads (Pure) -
High-Accuracy Augmented Reality Guidance for Intracranial Drain Placement Using a Standalone Head-Worn Navigation System: First-in-Human Results
Van Gestel, F., Frantz, T., Buyck, F., Gallagher, A. G., Geens, W., Neuville, Q., Bruneau, M., Jansen, B., Scheerlinck, T., Vandemeulebroucke, J. & Duerinck, J., Jun 2025, In: Neurosurgery. 96, 6, p. 1217-1226 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Citations (Scopus)4 Downloads (Pure)
Activities
- 4 Talk or presentation at a conference
-
Prognostic value of 0-(2-[18F]-fluoroethyl)-L-tyrosine PET in patients with recurrent glioblastoma.
Geens, W. (Speaker), Du Four, S. (Contributor), VAN LAERE, S. (Contributor), Schwarze, J. K. (Contributor), Awada, G. (Contributor), Bruneau, M. (Contributor), Tijtgat, J. (Contributor), Everaert, H. (Contributor), Neyns, B. (Contributor) & Duerinck, J. (Contributor)
26 Mar 2022Activity: Talk or presentation › Talk or presentation at a conference
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Geens, W. (Speaker), Schwarze, J. K. (Contributor), Bertels, C. (Contributor), Tijtgat, J. (Contributor), Awada, G. (Contributor), Vaeyens, F. (Contributor), Cras, L. (Contributor), Vanbinst, A. (Contributor), Everaert, H. (Contributor), Michotte, A. (Contributor), Janssen, T. (Contributor), Caljon, B. (Contributor), Cauwenbergh, T. (Contributor), Bruneau, M. (Contributor), Forsyth, R. (Contributor), Tuyaerts, S. (Contributor), Neyns, B. (Contributor) & Duerinck, J. (Contributor)
26 Mar 2022Activity: Talk or presentation › Talk or presentation at a conference
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Geens, W. (Speaker), Schwarze, J. K. (Contributor), Bertels, C. (Contributor), Tijtgat, J. (Contributor), Awada, G. (Contributor), Vaeyens, F. (Contributor), Cras, L. (Contributor), Vanbinst, A. (Contributor), Everaert, H. (Contributor), Michotte, A. (Contributor), Janssen, T. (Contributor), Caljon, B. (Contributor), Cauwenbergh, T. (Contributor), Bruneau, M. (Contributor), Forsyth, R. (Contributor) & Neyns, B. (Contributor)
26 Mar 2022Activity: Talk or presentation › Talk or presentation at a conference
-
Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): a multi-cohort adaptive phase I clinical trial
Schwarze, J. K. (Speaker), Geens, W. (Contributor), Tijtgat, J. (Contributor), Awada, G. (Contributor), Van Binst, A.-M. (Contributor), Everaert, H. (Contributor), Seynaeve, L. (Contributor), Michotte, A. (Contributor), Bruneau, M. (Contributor), VAN RIET, I. (Contributor), Tuyaerts, S. (Contributor), Duerinck, J. (Contributor) & Neyns, B. (Contributor)
16 Sept 2021 → 21 Sept 2021Activity: Talk or presentation › Talk or presentation at a conference